Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-06

Clinical Trial Update: Disappearance of Graves' Orbitopathy

View source ↗

Summary

A completed clinical trial by the University of Pisa in Thyroid Eye Disease reports disappearance of Graves' ophthalmopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pisa | Conditions: Thyroid Eye Disease | Status: COMPLETED